|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
TSA-II NeuroSensory Analyzer |
|
|
|
|
Una esencial prueba cuantitativa sensorial ( QST ) para la evaluación del nervio en la investigación y pruebas farmacológica. |
|
|
|
|
|
|
|
|
|
El TSA-II NeuroSensory Analyzer es un
dispositivo precisa, controlada
por un equipo
capaz de generar
y documentar las respuestas
a alta capacidad de repetición de
los estímulos térmicos y
de vibración, tales como
frío, calor, dolor
inducida por el frío, el dolor inducido
por el calor o vibración.
TSA-II
proporciona una evaluación cuantitativa de fibras
más pequeñas (A-delta y
fibras C)
de la función nerviosa sensorial, así
como el fibras finas A beta.
TSA-II
también se utiliza para identificar
un umbral de dolor térmico
en diversas aplicaciones
clínicas y de investigación. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
TSA-II - NeuroSensory Analyzer |
|
|
|
|
An essential Quantitative Sensory Testing (QST) tool for evaluating nerve impairment in clinical, research and
pharmacological trial settings |
|
|
|
|
|
|
|
|
|
The TSA-II NeuroSensory Analyzer is a precise, computer-controlled device capable of generating and documenting response to highly repeatable thermal and vibratory stimuli, such as warmth, cold, heat-induced pain, cold-induced pain or vibration. The
TSA-II delivers quantitative assessment of small-caliber (A-Delta and C-fiber) sensory
nerve function, as well as for large caliber A-Beta fibers. The TSA-II is also used for identifying thermal pain thresholds in various clinical and research applications. |
|
|
|
|
|
|
|
|
|
The test procedure
itself is similar to that employed in such routine tests as eye and
hearing examinations, where patients are asked to respond to visual
or auditory stimuli. The TSA-II thermode is placed on the patient's
skin to heat or cool the skin. Patients respond to the temperature
stimuli by pushing a button, and the sensory threshold is recorded
and automatically compared to an age-matched normative data. |
|
|
|
|
|
|
|
|
|
A deviation from
the normal range can indicate the existence of peripheral nerve
disease or damage due to injury, illness or toxic exposure. Testing
comparing contra-lateral body sites and longitudinal (or serial)
evaluation before and after therapy can also be routinely employed. |
|
|
|
|
|
|
|
|
|
Test result
reports are generated in a variety of graphical formats. |
|
|
|
|
|
|
|
|
|
TSA-II Features
|
|
|
|
|
• |
Outcome-based color graphic reports with automated narrative
discussion of test results for insurance and referral networks |
|
|
|
|
• |
Automatic comparison of test results to normative reference data |
|
|
|
|
• |
Portable, fast set-up and ease of use |
|
|
|
|
• |
Versatile WINDOWST based software with selection of test paradigms
for maximum flexibility in clinical, research and drug trial
applications. |
|
|
|
|
• |
Various test methods (Limits, Levels and Manual) |
|
|
|
|
• |
Factory installed default protocols for immediate clinical use |
|
|
|
|
• |
Proven Repeatability |
|
|
|
|
|
|
|
|
> Descargar Folleto TSA-II NeuroSensory Analyzer |
|
|
|
| Productos Medoc
|
TSA-II NeuroSensory Analyzer |
Accesorios TSA-II |
VSA-3000
|
AlgoMed
| |
|
|
|
|
Pathway |
Model Cheps |
Cheps Accesorios |
Covas |
Model ATS |
ATS Accesorios | |
|
